| Majd Jundi, MD | |
|
9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439-8207 | |
| (810) 733-7741 | |
| Not Available |
| Full Name | Majd Jundi |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 9460 S Saginaw Rd Ste D, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306430665 | NPI | - | NPPES |
| 1306430665 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4301501824 (Michigan) | Primary |
| Entity Name | Hills & Dales General Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154367001 PECOS PAC ID: 8022910363 Enrollment ID: O20040126000677 |
News Archive
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
› Verified 5 days ago
| Entity Name | Mckenzie Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497750608 PECOS PAC ID: 6406755289 Enrollment ID: O20040310000552 |
News Archive
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
› Verified 5 days ago
| Entity Name | Harbor Beach Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619059458 PECOS PAC ID: 7214903483 Enrollment ID: O20040908001458 |
News Archive
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
› Verified 5 days ago
| Entity Name | Flint Clinical Pathologist Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568570471 PECOS PAC ID: 2365419454 Enrollment ID: O20040916001168 |
News Archive
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
› Verified 5 days ago
| Entity Name | Flint Medical Laboratory Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760590665 PECOS PAC ID: 6103848353 Enrollment ID: O20051230000564 |
News Archive
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
› Verified 5 days ago
| Entity Name | Marlette Regional Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1346325214 PECOS PAC ID: 3971408121 Enrollment ID: O20070223000678 |
News Archive
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Majd Jundi, MD 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439-8207 Ph: (810) 733-7741 | Majd Jundi, MD 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439-8207 Ph: (810) 733-7741 |
News Archive
Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it had been awarded a $14 million contract to support the U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS). This five-year contract, which includes one base year and four option years, supports federal initiatives that require all facilities, which manufacture, process or hold FDA-regulated products to be registered with the Agency.
With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.
› Verified 5 days ago
Doina David, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-8898 | |
Dr. Khushi Sweety Lokesh Nagori, MBBS Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 | |
Baraa Alosh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-7741 | |
Alan F Henke, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5560 | |
Moutaz Haiba, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-8898 | |
Dr. Daniel Joseph Cowden, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 |